Joan M. Irizarry-Alvarado

Mayo Clinic in Florida

Papers

1

Total Citations

2

H-Index

1

About

Dr. Joan M. Irizarry-Alvarado is a distinguished researcher in nephrology and urologic surgery, with a focused expertise in the perioperative management of renal function. Her work critically examines how common cardiovascular medications impact kidney outcomes after surgical interventions. In her landmark study, "Retrospective Evaluation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Postoperative Estimated Glomerular Filtration Rates Following Robotic-Assisted Partial Nephrectomy" (2020), Dr. Irizarry-Alvarado investigated the association between preoperative ACEI/ARB use and changes in estimated glomerular filtration rate (eGFR) after robotic-assisted partial nephrectomy (RAPN). This research provides essential guidance for clinicians balancing cardiovascular protection with renal preservation in surgical patients. Though a growing contribution, her work has already garnered citations, signaling its relevance to evidence-based surgical nephrology. Dr. Irizarry-Alvarado’s dedication to bridging pharmacology and renal outcomes positions her as an emerging voice in optimizing postoperative kidney health, with implications for improving patient recovery and long-term renal function.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Retrospective Evaluation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Postoperative Estimated Glomerular Filtration Rates Following Robotic-Assisted Partial Nephrectomy
2 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Mayo Clinic in Florida

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago